Cite
HARVARD Citation
Zhu, Y. et al. (2020). Evaluating Potential Disease‐Mediated Protein‐Drug Interactions in Patients With Moderate‐to‐Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab. Clinical and translational science. 13 (6), pp. 1217-1226. [Online].